✦ LIBER ✦

LIGHT is preferentially expressed on activated mucosal CD4+ and CD8+ T cells and augments CD2 mediated IFNγ production

✍ Scribed by Offer Cohavy; John Prehn; Carl Ware; Stephan R. Targan

Book ID: 119427617
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 176 KB
Volume: 124
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(03)80759-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The tetraspanin CD9 is preferentially ex

The tetraspanin CD9 is preferentially expressed on the human CD4+CD45RA+ naive T cell population and is involved in T cell activation

✍ H. KOBAYASHI; O. HOSONO; S. IWATA; H. KAWASAKI; M. KUWANA; H. TANAKA; N. H. DANG 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

Effector CD4 cell tolerization is mediat

Effector CD4 cell tolerization is mediated through functional inactivation and involves preferential impairment of TNF-α and IFN-γ expression potentials

✍ Meixiao Long; Amy D. Higgins; Marianne A. Mihalyo; Adam J. Adler 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Staphylococcus aureus skin colonization

Staphylococcus aureus skin colonization in atopic dermatitis children is associated with decreased IFN-γ production by peripheral blood CD4+ and CD8+ T cells

✍ Edyta Machura; Bogdan Mazur; Ewa Golemiec; Mariola Pindel; Franciszek Halkiewicz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Inhibition of T cell responses by activa

Inhibition of T cell responses by activated CD8+ T cells is mediated by IFN-γ and is defective in chronic progressive multiple sclerosis

✍ K.E. Balashov; S.J. Khoury; H.L. Weiner 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Cyclophosphamide modulates CD4+ T cells

Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-γ production of CD8+ T cells in secondary progressive multiple sclerosis

✍ Arnon Karni; Konstantin Balashov; Wayne W. Hancock; Padmanabhan Bharanidharan; M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 505 KB

Cure of established GL261 mouse gliomas

Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNγ is mediated by both CD8+ and CD4+ T-cells

✍ Karin Enell Smith; Sara Fritzell; Wiaam Badn; Sofia Eberstål; Shorena Janelidze; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 316 KB

## Abstract We were the first to demonstrate that combined immunotherapy with GM‐CSF producing GL261 cells and recombinant IFNγ of preestablished GL261 gliomas could cure 90% of immunized mice. To extend these findings and to uncover the underlying mechanisms, the ensuing experiments were undertake